Edesa Biotech公布了其药物Paridiprubart在治疗急性肾损伤患者中获得的积极探索性数据。这一进展为该公司在该治疗领域的研究提供了新的动力与希望。
Edesa Biotech公布了其药物Paridiprubart在治疗急性肾损伤患者中获得的积极探索性数据。这一进展为该公司在该治疗领域的研究提供了新的动力与希望。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.